Scientists develop a blood test to predict how long brain cancer patients will survive

Researchers at the University of Pennsylvania found that glioblastoma patients with higher levels of a biomarker in their blood lived on average half as long after diagnosis and discovered new mutations.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news